Lazard Asset Management
ELAN icon

Lazard Asset Management’s Elanco Animal Health ELAN Stock Holding History

Lazard Asset Management’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.34M Buy
95,219
+5,065
+6% +$117K ﹤0.01% 917
2026
Q1 		$2.16M Buy
90,154
+18,089
+25% +$442K ﹤0.01% 859
2025
Q4 		$1.63M Buy
72,065
+425
+0.6% +$9.25K ﹤0.01% 960
2025
Q3 		$1.44M Sell
71,640
-1,341
-2% -$22.5K ﹤0.01% 994
2025
Q2 		$1.04M Buy
72,981
+65,656
+896% +$767K ﹤0.01% 1287
2025
Q1 		$76K Sell
7,325
-21,681
-75% -$245K ﹤0.01% 1887
2024
Q4 		$350K Buy
29,006
+25,109
+644% +$329K ﹤0.01% 1465
2024
Q3 		$57K Buy
3,897
+3,794
+3,683% +$52.9K ﹤0.01% 1893
2024
Q2 		$1K Buy
+103
New +$1.65K ﹤0.01% 2138
2024
Q1 		– Sell
-103
Closed -$1K – 2130
2023
Q4 		$1K Hold
103
– – ﹤0.01% 2197
2023
Q3 		$1K Sell
103
-3,664
-97% -$42.6K ﹤0.01% 2220
2023
Q2 		$37K Buy
3,767
+53
+1% +$492 ﹤0.01% 1924
2023
Q1 		$34K Buy
3,714
+2,967
+397% +$35K ﹤0.01% 1915
2022
Q4 		$9K Buy
747
+29
+4% +$361 ﹤0.01% 2207
2022
Q3 		$8K Buy
718
+677
+1,651% +$11.8K ﹤0.01% 2159
2022
Q2 		$0 Buy
41
+22
+116% +$521 ﹤0.01% 2430
2022
Q1 		$0 Buy
+19
New +$506 ﹤0.01% 2378
2020
Q1 		– Sell
-14,193,741
Closed -$418M – 1615
2019
Q4 		$418M Buy
14,193,741
+396,920
+3% +$10.8M 0.6% 45
2019
Q3 		$367M Sell
13,796,821
-1,261,813
-8% -$37.9M 0.6% 43
2019
Q2 		$509M Buy
15,058,634
+4,417,670
+42% +$143M 0.83% 30
2019
Q1 		$341M Buy
+10,640,964
New +$327M 0.56% 51

Other funds holding ELAN

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Lazard Asset Management's ELAN Position: Q2 2026 in Review

Lazard Asset Management increased its Elanco Animal Health (ELAN) stake by 5.6% in Q2 2026, buying an estimated $117K and bringing the position to 95,219 shares worth $2.34M. The position accounts for ﹤0.01% of the portfolio, ranked #917.

Lazard Asset Management first reported a position in ELAN in Q1 2019 and has held it in 21 quarters since. The position peaked at $509M in Q2 2019. 520 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • Lazard Asset Management held 95,219 shares of Elanco Animal Health worth $2.34M as of Q2 2026.
  • Lazard Asset Management bought 5,065 Elanco Animal Health shares in Q2 2026, an estimated $117K.
  • Elanco Animal Health made up ﹤0.01% of Lazard Asset Management's portfolio in Q2 2026, its #917 holding.
  • Lazard Asset Management first reported a position in Elanco Animal Health in Q1 2019 and has held it in 21 quarters since.
  • Lazard Asset Management's Elanco Animal Health position peaked at $509M in Q2 2019.
  • 520 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Lazard Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.